Nandrolone (Deca-Durabolin) vs Thyroid (Levothyroxine / Liothyronine T3/T4)

Mechanism

Nandrolone decanoate is a 19-nortestosterone derivative that binds the androgen receptor with high affinity but undergoes 5-alpha reduction to dihydronandrolone (DHN), a weaker androgen than DHT, resulting in reduced androgenic side effects. It stimulates collagen synthesis via upregulation of prolyl 4-hydroxylase and galactosylhydroxylysyl glucosyltransferase, increasing type III collagen production in tendons, ligaments, and joint capsules. Nandrolone also increases synovial fluid production and glycosaminoglycan content, and stimulates bone mineral density through direct osteoblast AR activation and IGF-1 modulation.

Standard Dosing

Research indicates 50-200 mg administered via intramuscular injection every 7-14 days for joint/collagen therapeutic protocols.

Timing

Inject on the same day as testosterone for convenience. Deep intramuscular injection in gluteal or deltoid muscle. Full collagen synthesis benefits require 8-12 weeks minimum.

Cycle Duration

12-16 week cycles for joint/collagen repair. Some clinical protocols extend to 6 months under medical supervision.

Side Effects

• Suppression of endogenous testosterone (profound — must co-administer testosterone)
• Progesterone-mediated gynecomastia
• Erectile dysfunction ('Deca dick' from DHN displacement of DHT at neural AR)
• Fluid retention and edema
• Increased hematocrit
• Mood changes (depression reported in some users)
• Acne (less than testosterone)

Contraindications

• Prostate cancer
• Male breast cancer
• Severe hepatic impairment
• Nephrotic syndrome
• Pregnancy
• Hypercalcemia
• Known hypersensitivity to nandrolone or carrier oil

Best Stacking Partners

Mechanism

Levothyroxine (T4) is a prohormone converted to the active triiodothyronine (T3) by type 1 and type 2 deiodinase enzymes (DIO1/DIO2) in peripheral tissues. T3 binds nuclear thyroid hormone receptors (TRa and TRb), forming heterodimers with retinoid X receptors (RXR) that bind thyroid response elements (TREs) in DNA, directly modulating transcription of genes controlling basal metabolic rate, thermogenesis, mitochondrial biogenesis (via PGC-1a), cardiac output, and neuronal development. T3 also exerts rapid non-genomic effects on mitochondrial respiration, ion channels, and cell membrane transport.

Standard Dosing

Research indicates Levothyroxine (T4): 25-200 mcg daily based on TSH and free T4 levels. Liothyronine (T3): 5-25 mcg daily, often split into 2-3 doses. Combination T4/T3 ratio typically 4:1 to 3:1 when using both.

Timing

Levothyroxine: Take on empty stomach, 30-60 minutes before breakfast or at bedtime (3+ hours after last meal). Separate from calcium, iron, and antacids by 4 hours. Liothyronine: Split into 2-3 daily doses due to short half-life (2.5 hours for T3 vs. 6-7 days for T4).

Cycle Duration

Ongoing for diagnosed hypothyroidism. Optimization protocols may be shorter-term (3-6 months) with reassessment.

Side Effects

• Tachycardia and palpitations (overdose or too-rapid titration)
• Anxiety and insomnia (particularly with T3)
• Tremor
• Weight loss (excessive dosing)
• Hair loss (temporary during initiation or dose changes)
• Heat intolerance and sweating
• Bone density loss at suppressive doses (TSH <0.1)

Contraindications

• Untreated adrenal insufficiency (correct cortisol before thyroid replacement)
• Acute myocardial infarction
• Thyrotoxicosis
• Known hypersensitivity to levothyroxine or liothyronine

Best Stacking Partners